报价延迟最少15分钟:2026/03/09 20:35 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.81 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
1.36/2.81
|
|
企业价值
214.62B
|
| 资产负债 |
|
每股账面净值
15.21
|
| 现金流量 |
|
现金流量率
0.08
|
| 损益表 |
|
收益
62.58B
|
|
每股收益
12.05
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. |
